HomeStock ScreenerEmmessar BiotechQuarterly Results

Emmessar Biotech Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹0 Cr
QMarch 2025
Quarterly Results

In 2026, Emmessar Biotech (EMMESSA) reported revenue ₹3 Cr and net profit ₹0 Cr. For annual financials, live price and key ratios, visit Emmessar Biotech stock price NSE.

EMMESSA Quarterly Results — Revenue, Profit & EPS Highlights

Emmessar Biotech latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Compare with Emmessar Biotech valuation methods to assess whether the stock is under or overvalued.

  • Revenue of ₹3 Cr in March 2025 (+0.0% vs March 2025, +0.0% vs March 2024)
  • EBITDA of ₹1 Cr in March 2025 (+0.0% vs March 2025)
  • Operating Margin of -156.0% in March 2025 (+0.0pp vs March 2025)
  • Earnings Per Share of ₹0.63 in March 2025 (+0.0% vs March 2025)

Emmessar Biotech Quarterly Results — Revenue, EBITDA, Net Profit & EPS

EMMESSA quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric 2026 March 2025 March 2024 March 2023 March 2022 QoQ YoY
Revenue (₹ Cr) 3 3 3 3 2 - -
Net Profit (₹ Cr) 0 0 1 1 1 - -
EBITDA (₹ Cr) 1 1 1 1 1 - -
EPS (₹) 0.60 0.63 1.50 0.99 0.94 - -
Operating Margin (%) -355.0% -156.0% -195.0% -68.0% -245.0% - -

EMMESSA Share Price Trend — 1-Year Movement Across Quarterly Results

Emmessar Biotech 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Also explore EMMESSA price movement history to track price trends across different timeframes.

Profitability Ratios

EBITDA Margin 33.3%
Operating Margin -156.0%

Balance Sheet Highlights

Total Assets ₹9 Cr
Total Equity ₹8 Cr
Current Assets ₹7 Cr
Current Liabilities ₹1 Cr

Cash Flow Analysis

Operating Cash Flow ₹0 Cr
Investing Cash Flow ₹0 Cr
Financing Cash Flow ₹0 Cr
Net Cash Flow ₹0 Cr

Current Market Data

Current Price ₹25.41
Exchange BSE
Last Updated May 08, 2026

EMMESSA vs Chemicals Peers — Quarterly Revenue, Profit & Market Cap

Emmessar Biotech latest quarter revenue and net profit vs Chemicals competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Pidilite Industries
Sept 2025
₹144,675.48 Cr 1476.0 3,605 585 +11.9% - 16.2% 259.4
SRF
Mar 2026
₹80,476.38 Cr 2780.8 4,557 582 +28.0% +7.2% 12.8% 141.7
Linde
Sept 2025
₹63,984.49 Cr 7808.5 650 171 +7.4% - 26.3% 389.5
Coromandel Internat…
Sept 2025
₹59,489.70 Cr 1927.6 9,771 793 +78.9% - 8.1% 70.5
Fertilisers & Chemi…
Sept 2025
₹59,174.73 Cr 904.6 1,681 21 +48.8% - 1.2% 2826.9
Sector Quarterly Performance Comparison
Chemicals sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores